Fate Therapeutics Inc (FATE): A Nice Stem Cell Play – iStockAnalyst (press release)
|
Fate Therapeutics Inc (FATE): A Nice Stem Cell Play
iStockAnalyst (press release) Fate Therapeutics Inc. (NASDAQ: FATE) shares should benefit from the company’s expertise in both in-vivo and ex-vivo stem cell modulation that should be leveragable across multiple orphan indications, including stem cell transplant in cancer, lysosomal … |
